ArticleBiological psychiatry2020

Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder.

Sophia Attwells et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.